News
-
Supply crunch with replica drug ban
Friday | May 24 2024PATIENTS who legitimately need compounded Ozempic should still have access to the medication, even if a government ban comes into effect, advises the Consumers Health Forum of Australia (CHF).
-
New contraception course
Friday | May 24 2024QUEENSLAND pharmacists can commence their full scope of practice journey with the newly launched Prescribing Hormonal Contraceptives Course by the Australasian College of Pharmacy.
-
Aussie CMs’ growth “a success story”
Friday | May 24 2024A SURGE in international and local demand has led to complementary medicines becoming a huge success story for Australia, according to peak body Complementary Medicines Australia.
-
24/7 assistance
Friday | May 24 2024DISPENSE Assist is highlighting how it can help pharmacy owners deal with staffing and cost challenges with its fully qualified technicians available 24/7.
-
Insures scope pilots
Friday | May 24 2024FOR 60 years, Guild Insurance has protected all Guild members real-life needs, and will continue to support them as scope of practice pilots increase.
-
FIP campaign
Friday | May 24 2024A GLOBAL campaign has been launched today to raise awareness of pharmacies as places of primary healthcare, and to advocate for the profession, primarily in the minds of policy makers and other target groups.
-
LIPPE to fill gaps
Friday | May 24 2024PHARMACY educators have a new platform to explore learning resources aimed at embedding Indigenous knowledge and expertise into Western-style pharmacy education and training.
-
J&J’s talc lawsuit
Friday | May 24 2024IN RESPONSE to the latest talc lawsuit in the US against Johnson & Johnson (J&J), the company has offered claimants one of the largest payouts in the history of mass tort litigation (PD 23 May).
-
Dispensary Corner 24 May 24
Friday | May 24 2024IF YOU thought fish oil capsules were your heart's best friend, think again.
-
J&J latest US talc lawsuit
Thursday | May 23 2024CANCER patients in the US are suing Johnson & Johnson (J&J), accusing it of committing fraud by using a shell company's bankruptcy to settle thousands of lawsuits, reported Reuters.